Emerging Diagnostic Technology: Objective Biomarkers and FDA-Cleared Tools While existing tools represent decades of clinical ...

D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate ...

Recent research is helping to expand the potential biomarker landscape in non–small cell lung cancer (NSCLC) and may soon ...

A team of scientists from NTU Singapore has developed a new biochip that, when paired with artificial intelligence, can ...

Researchers at the University, with Tezpur University, uncovered new chemical markers that can help detect gallbladder cancer ...

With a NOK 40 million (approx. €3.5 million) grant, Professor Srdjan Djurovic at the University of Oslo aims to identify early blood-based biomarkers that can predict who is at increased risk of ...

Interest in biomarkers has exploded in recent years, driven by improvements in data collection and analysis, burgeoning interest in personalized medicine, and efforts to increase the success rate for ...

DNADX high scores predicted improved PFS, supporting genomic instability and DNA repair deficiency as biologically relevant ...

Researchers have identified six new biomarkers that could detect kidney injury faster and with more sensitivity, advancing safer drug development and improving health outcomes for patients. The new ...

Alzheimer’s disease is a neurodegenerative condition that can cause difficulties with thinking and memory and physical decline. Biomarkers can help experts monitor its development, progression, and ...

According to MarketsandMarkets™, the Digital Biomarkers Market is projected to grow from about USD 7.41 billion in 2026 to USD 17.73 billion by 2031, at a CAGR of 19.1%.